Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07198516 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver:

StatusNot Yet Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 30, 2025 (before its estimated September 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
To evaluate the effect and safety of Henggliejin on fatty liver in type 2 diabetes patients with nonalcoholic fatty liver disease
Trial Details
NCT Number NCT07198516
Lead Sponsor Fujian Medical University Union Hospital
Conditions
(from sponsor)		 NAFLD, Diabete Type 2
Related terms Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease
Enrollment 149 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov